Study Sheds Light on the Effects of Background Medications on Lupus Clinical Trials
In this podcast, Dr. Kenneth Kalunian of the University of California at San Diego, discusses the results of a Lupus Foundation of America led study to examine the effect of background medications taken by individuals enrolled in lupus clinical trials. This study is the first in a series of studies, and part of an overall initiative spearheaded by the Foundation that involves stakeholders from industry and key lupus opinion leaders to seek insights and trends from previous trials in an effort to improve the design of future lupus clinical trials. The results were presented during the 2011 American College of Rheumatology Annual Scientific Meeting.
Presenter: Kenneth C. Kalunian, MD
Presentation date: November 8, 2011
Length: Six minutes